Horrell Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $150K | Hold |
300
| – | – | 0.07% | 72 |
|
|
2026
Q1 | $147K | Hold |
300
| – | – | 0.07% | 69 |
|
|
2025
Q4 | $174K | Hold |
300
| – | – | 0.08% | 67 |
|
|
2025
Q3 | $146K | Hold |
300
| – | – | 0.06% | 75 |
|
|
2025
Q2 | $122K | Hold |
300
| – | – | 0.05% | 74 |
|
|
2025
Q1 | $139K | Hold |
300
| – | – | 0.06% | 68 |
|
|
2024
Q4 | $156K | Hold |
300
| – | – | 0.05% | 94 |
|
|
2024
Q3 | $186K | Hold |
300
| – | – | 0.06% | 92 |
|
|
2024
Q2 | $166K | Hold |
300
| – | – | 0.05% | 91 |
|
|
2024
Q1 | $174K | Hold |
300
| – | – | 0.05% | 100 |
|
|
2023
Q4 | $159K | Hold |
300
| – | – | 0.05% | 98 |
|
|
2023
Q3 | $152K | Hold |
300
| – | – | 0.05% | 97 |
|
|
2023
Q2 | $157K | Hold |
300
| – | – | 0.05% | 97 |
|
|
2023
Q1 | $173K | Hold |
300
| – | – | 0.05% | 95 |
|
|
2022
Q4 | $165K | Hold |
300
| – | – | 0.05% | 93 |
|
|
2022
Q3 | $152K | Hold |
300
| – | – | 0.06% | 92 |
|
|
2022
Q2 | $163K | Hold |
300
| – | – | 0.06% | 89 |
|
|
2022
Q1 | $177K | Hold |
300
| – | – | 0.06% | 90 |
|
|
2021
Q4 | $200K | Hold |
300
| – | – | 0.06% | 88 |
|
|
2021
Q3 | $171K | Hold |
300
| – | – | 0.07% | 83 |
|
|
2021
Q2 | $151K | Hold |
300
| – | – | 0.06% | 82 |
|
|
2021
Q1 | $137K | Hold |
300
| – | – | 0.05% | 80 |
|
|
2020
Q4 | $140K | Hold |
300
| – | – | 0.06% | 75 |
|
|
2020
Q3 | $132K | Hold |
300
| – | – | 0.06% | 75 |
|
|
2020
Q2 | $109K | Hold |
300
| – | – | 0.05% | 77 |
|
|
2020
Q1 | $85K | Hold |
300
| – | – | 0.05% | 79 |
|
|
2019
Q4 | $98K | Hold |
300
| – | – | 0.05% | 81 |
|
|
2019
Q3 | $87K | Hold |
300
| – | – | 0.04% | 92 |
|
|
2019
Q2 | $88K | Hold |
300
| – | – | 0.04% | 87 |
|
|
2019
Q1 | $82K | Sell |
300
-100
| -25% | -$24.9K | 0.04% | 92 |
|
|
2018
Q4 | $90K | Sell |
400
-100
| -20% | -$23.5K | 0.05% | 94 |
|
|
2018
Q3 | $122K | Hold |
500
| – | – | 0.06% | 89 |
|
|
2018
Q2 | $104K | Hold |
500
| – | – | 0.05% | 91 |
|
|
2018
Q1 | $103K | Hold |
500
| – | – | 0.05% | 91 |
|
|
2017
Q4 | $95K | Hold |
500
| – | – | 0.05% | 93 |
|
|
2017
Q3 | $95K | Hold |
500
| – | – | 0.05% | 94 |
|
|
2017
Q2 | $87K | Hold |
500
| – | – | 0.05% | 91 |
|
|
2017
Q1 | $77K | Hold |
500
| – | – | 0.05% | 93 |
|
|
2016
Q4 | $71K | Hold |
500
| – | – | 0.04% | 93 |
|
|
2016
Q3 | $80K | Hold |
500
| – | – | 0.05% | 91 |
|
|
2016
Q2 | $74K | Hold |
500
| – | – | 0.05% | 93 |
|
|
2016
Q1 | $71K | Hold |
500
| – | – | 0.04% | 93 |
|
|
2015
Q4 | $71K | Hold |
500
| – | – | 0.04% | 96 |
|
|
2015
Q3 | $61K | Hold |
500
| – | – | 0.04% | 103 |
|
|
2015
Q2 | $65K | Hold |
500
| – | – | 0.04% | 113 |
|
|
2015
Q1 | $67K | Sell |
500
-300
| -38% | -$38.7K | 0.03% | 166 |
|
|
2014
Q4 | $100K | Hold |
800
| – | – | 0.04% | 145 |
|
|
2014
Q3 | $97K | Hold |
800
| – | – | 0.05% | 151 |
|
|
2014
Q2 | $94K | Hold |
800
| – | – | 0.04% | 158 |
|
|
2014
Q1 | $96K | Hold |
800
| – | – | 0.05% | 148 |
|
|
2013
Q4 | $88K | Sell |
800
-200
| -20% | -$19.9K | 0.04% | 150 |
|
|
2013
Q3 | $92K | Hold |
1,000
| – | – | 0.05% | 139 |
|
|
2013
Q2 | $85K | Buy |
+1,000
| New | +$83.2K | 0.05% | 145 |
|
Other funds holding TMO
Horrell Capital Management's TMO Position: Q2 2026 in Review
Horrell Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 300 shares worth $150K. The position accounts for 0.07% of the portfolio, ranked #72.
Horrell Capital Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $200K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Horrell Capital Management held 300 shares of Thermo Fisher Scientific worth $150K as of Q2 2026.
- Horrell Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.07% of Horrell Capital Management's portfolio in Q2 2026, its #72 holding.
- Horrell Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Horrell Capital Management's Thermo Fisher Scientific position peaked at $200K in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Horrell Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.